Delivery Order SPE2DB22D3004-SPE2DB25FRY58
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $2,428.44 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of 4,564,712 units of Topiramate 25 mg sprinkle capsules. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of...
- The Defense Logistics Agency awarded a $3,273.32 delivery order to AmerisourceBergen Drug Corp for Topiramate ER 100 mg capsules (30-count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Topiramate is a generic anticonvulsant and mood-stabilizing medication commonly used in military and...
- The Defense Logistics Agency has awarded a delivery order valued at $35,132.55 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets in quantities of 500 units. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 5, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $6,774.81 delivery order to AmerisourceBergen Drug Corp for Topiramate ER 100 mg capsules (30-count units) on July 25, 2025, with completion scheduled for July 28, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and active through December 2026. The pharmaceutical distributor,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,109.80 firm fixed-price delivery order is for the supply of 4,566,211,014 units of Topiramate 25 mg sprinkle capsules. The contract has an ultimate completion date of October 28, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,580.74 to AmerisourceBergen Drug Corp for the supply of Topiramate 50 mg tablets (1,000 count) under a firm fixed price contract. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in...
- This is a $13,764.92 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of topiramate 25 mg sprinkle capsules, a medication used for the treatment of certain neurological conditions. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 200 mg Topiramate ER capsules. The $48,858.73 contract has an ultimate completion date of April 10, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical products from its Corporate Office location in Conshohocken, Pennsylvania to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Topiramate 25 mg tablets in quantities of 500 units, with a ceiling value of $4,748.01 and an ultimate completion date of August 1, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,365.81 to AmerisourceBergen Drug Corp for Topiramate ER 200 mg capsules (30-count units) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's Conshohocken, Pennsylvania...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRY58Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,159.74 to AmerisourceBergen Drug Corp for the supply of Topiramate 15 mg sprinkle capsules (60-count units) under a firm fixed-price contract. This non-set-aside delivery order was executed on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Topiramate is a generic anticonvulsant and migraine prevention medication commonly utilized within military and federal healthcare systems. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal medical procurement, maintains this comprehensive prime vendor agreement to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. The company's competitively awarded contract portfolio with DLA demonstrates its established capability to fulfill federal pharmaceutical distribution requirements across multiple therapeutic domains for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/12/25 |